Michael Egholm

Insider Reports History

Entity
Individual
Location
1 Franklin Street, Unit 3104, Boston, MA
Signature
/s/ Michael Egholm by Hanjoon Alex Kim, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Egholm:

Stock Role Class Num Shares Value Price $ Report Date Ownership
STANDARD BIOTOOLS INC. President & CEO, Director Stock Option (Right to buy) 1.78M $3.32M $1.86 Mar 21, 2025 Direct
STANDARD BIOTOOLS INC. President & CEO, Director Common Stock 2.77M $2.97M $1.07 Apr 4, 2025 Direct
STANDARD BIOTOOLS INC. President & CEO, Director Restricted Stock Units 197K $210K $1.07 Apr 4, 2025 Direct
IsoPlexis Corp Director Stock Option 89K Jun 16, 2022 Direct

Insider Reports Filed by Michael Egholm

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LAB STANDARD BIOTOOLS INC. Apr 4, 2025 3 -$61.7K 4 Apr 8, 2025 President & CEO, Director
LAB STANDARD BIOTOOLS INC. Mar 21, 2025 2 $0 4 Mar 24, 2025 President & CEO, Director
LAB STANDARD BIOTOOLS INC. Feb 20, 2025 1 -$43.1K 4 Feb 24, 2025 President & CEO, Director
LAB STANDARD BIOTOOLS INC. Nov 20, 2024 1 -$43.5K 4 Nov 21, 2024 President & CEO, Director
LAB STANDARD BIOTOOLS INC. Aug 20, 2024 1 -$55.6K 4 Sep 5, 2024 President & CEO, Director
LAB STANDARD BIOTOOLS INC. May 20, 2024 2 $0 4 May 21, 2024 President & CEO, Director
LAB STANDARD BIOTOOLS INC. Apr 8, 2024 1 -$278K 4 Apr 9, 2024 President & CEO, Director
LAB STANDARD BIOTOOLS INC. Jan 5, 2024 4 $0 4 Apr 5, 2024 President & CEO, Director
LAB STANDARD BIOTOOLS INC. Apr 4, 2023 2 $0 4 Apr 6, 2023 President & CEO, Director
ISO IsoPlexis Corp Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
LAB STANDARD BIOTOOLS INC. Apr 4, 2022 2 $0 4 Apr 6, 2022 President & CEO, Director
LAB STANDARD BIOTOOLS INC. Apr 4, 2022 0 $0 3 Apr 6, 2022 President & CEO, Director
ISO IsoPlexis Corp Oct 7, 2021 0 $0 3 Oct 7, 2021 Director